By Priyanka Sharma ANI | Updated: Dec 16 2020 21:00 IST New Delhi [India], Dec 16 (ANI): With the start of Covid vaccination, an immediate future in India, the phase III clinical trial for Bharat Biotech’s locally developed COVAXIN vaccine candidate is witnessing a shortage of volunteer participation, with a …
Read More »70-80 pc reduction in participation in the COVAXIN trial: AIIMS physician
